Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acorda Therapeutics Inc. (ACOR)

4.41   0.05 (1.15%) 09-23 14:53
Open: 4.37 Pre. Close: 4.36
High: 4.49 Low: 4.37
Volume: 29,963 Market Cap: 49M
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops Inbrija for the treatment of OFF periods in Parkinson's disease and ARCUS product for the treatment of acute migraine. Further, it develops rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa that is in Phase Ib clinical trial for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.432 - 4.454 4.454 - 4.476
Low: 4.229 - 4.252 4.252 - 4.274
Close: 4.324 - 4.359 4.359 - 4.396

Technical analysis

as of: 2021-09-23 2:39:23 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.72     One year: 6.68
Support: Support1: 4.08    Support2: 3.57
Resistance: Resistance1: 4.90    Resistance2: 5.72
Pivot: 4.49
Moving Average: MA(5): 4.44     MA(20): 4.42
MA(100): 4.17     MA(250): 4.79
MACD: MACD(12,26): 0.12     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 40.74     %D(3): 42.84
RSI: RSI(14): 54.42
52-week: High: 9.84  Low: 2.88  Change(%): 19.9
Average Vol(K): 3-Month: 111555  10-Days: 12515

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACOR has closed above bottom band by 46.4%. Bollinger Bands are 38.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 21 Sep 2021
Acorda (ACOR) falls 1.84% to Close at $4.28 on September 21 -

Mon, 20 Sep 2021
Form 3/A ACORDA THERAPEUTICS INC For: Sep 09 Filed by: Clem Kerry M -

Thu, 09 Sep 2021
Acorda Therapeutics Announces Corporate Restructuring, Management Changes - Business Wire

Wed, 25 Aug 2021
Acorda (ACOR) gains 3.45% for August 25 -

Thu, 05 Aug 2021
Acorda Therapeutics Reports Second Quarter 2021 Financial Results - Business Wire

Thu, 22 Jul 2021
Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 11
Shares Float (M) 8
% Held by Insiders 1.85
% Held by Institutions 39.92
Shares Short (K) 1,430
Shares Short P. Month (K) 1,190

Stock Financials

EPS -14.959
EPS Est This Year 1.750
EPS Est Next Year 0.700
Book Value (p.s.) 21.780
Profit Margin -82.34
Operating Margin -53.15
Return on Assets (ttm) -7.6
Return on Equity (ttm) -49.3
Qtrly Rev. Growth 2.7
Gross Profit (p.s.) 8.703
Sales Per Share 13.825
EBITDA (p.s.) -3.810
Qtrly Earnings Growth
Operating Cash Flow (M) -49
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -0.30
PEG Ratio
Price to Book value 0.20
Price to Sales 0.32
Price to Cash Flow -1.01

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2021-01-03
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.